• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HNF-1α 突变携带者中糖尿病(青年发病型糖尿病3型)发生的决定因素:亲本来源效应的证据

Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect.

作者信息

Klupa Tomasz, Warram James H, Antonellis Anthony, Pezzolesi Marcus, Nam Moonsuk, Malecki Maciej T, Doria Alessandro, Rich Stephen S, Krolewski Andrzej S

机构信息

Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

Diabetes Care. 2002 Dec;25(12):2292-301. doi: 10.2337/diacare.25.12.2292.

DOI:10.2337/diacare.25.12.2292
PMID:12453976
Abstract

OBJECTIVE

To determine the distribution of the age at onset of diabetes (maturity-onset diabetes of the young-3 [MODY3]) and to identify determinants of the onset of diabetes in carriers of HNF-1alpha mutations.

RESEARCH DESIGN AND METHODS

Extended families (n = 104) with type 2 diabetes inherited in a dominant pattern were recruited and screened for diabetes-causing mutations in HNF-1alpha.

RESULTS

HNF-1alpha mutations cosegregated with diabetes in only 13 families, all with a mean age at onset <35 years. Insulin secretion was diminished or absent in mutation carriers (n = 101), and diabetes developed in 65% by age 25 years and in 100% by age 50 years. If the mutation was inherited from the mother, diabetes onset was very young in those exposed to diabetes in utero; 57 +/- 8% were affected by age 15 years as compared with 0.0% in those not exposed (P < 7 x 10(-6)). By age 25 years, the difference was reduced (85 +/- 6 and 55 +/- 12%, respectively; P = 0.02). If the mutation was inherited from the father, diabetes developed in 52 +/- 8% by age 25 years. Age at diagnosis was shown to be highly heritable (h(2) = 0.47, P = 0.003). When parent of origin was included in the analyses, the magnitude of genetic contribution increased markedly (h(2) = 0.91).

CONCLUSIONS

Mutations in HNF-1alpha accounts for diabetes in a small proportion of families with a dominant pattern of inheritance. Age at onset of diabetes in MODY3 families varied widely and was influenced by familial factors (including modifying genes) and parent of origin (whether a mutation carrier was exposed to diabetes in utero).

摘要

目的

确定糖尿病(青年发病型成年糖尿病3型[MODY3])的发病年龄分布,并确定HNF-1α突变携带者中糖尿病发病的决定因素。

研究设计与方法

招募以显性方式遗传的2型糖尿病大家庭(n = 104),并对HNF-1α中的糖尿病致病突变进行筛查。

结果

HNF-1α突变仅在13个家庭中与糖尿病共分离,所有家庭的平均发病年龄均<35岁。突变携带者(n = 101)的胰岛素分泌减少或缺乏,65%的人在25岁时患糖尿病,100%的人在50岁时患糖尿病。如果突变是从母亲遗传而来,子宫内暴露于糖尿病的个体糖尿病发病非常早;15岁时57±8%的个体受影响,而未暴露个体中这一比例为0.0%(P < 7×10⁻⁶)。到25岁时,差异缩小(分别为85±6%和55±12%;P = 0.02)。如果突变是从父亲遗传而来,25岁时52±8%的个体患糖尿病。诊断年龄显示具有高度遗传性(h² = 0.47,P = 0.003)。当分析中纳入亲本来源时,遗传贡献的程度显著增加(h² = 0.91)。

结论

HNF-1α突变在一小部分显性遗传模式的家庭中导致糖尿病。MODY3家庭中糖尿病的发病年龄差异很大,受家族因素(包括修饰基因)和亲本来源(突变携带者是否在子宫内暴露于糖尿病)的影响。

相似文献

1
Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect.HNF-1α 突变携带者中糖尿病(青年发病型糖尿病3型)发生的决定因素:亲本来源效应的证据
Diabetes Care. 2002 Dec;25(12):2292-301. doi: 10.2337/diacare.25.12.2292.
2
Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.肝细胞细胞核因子(HNF)-1α、-4α、-1β和-3β基因;HNF-1的二聚化辅助因子;以及胰岛素启动因子1的突变并非皮马印第安人早发型2型糖尿病的常见病因。
Diabetes Care. 2000 Mar;23(3):302-4. doi: 10.2337/diacare.23.3.302.
3
Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers.子宫内高血糖与HNF-1α基因突变携带者糖尿病的早期诊断相关。
Diabetes Care. 2002 Dec;25(12):2287-91. doi: 10.2337/diacare.25.12.2287.
4
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.青少年发病的成年型糖尿病及早发型非胰岛素依赖型糖尿病中肝细胞核因子-1α基因的突变:外显子4存在突变热点的证据
Diabetes. 1997 Mar;46(3):528-35. doi: 10.2337/diab.46.3.528.
5
Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24.肝细胞细胞核因子-1α突变携带者中糖尿病诊断年龄的遗传修饰因子(MODY3)定位于5号染色体p15、9号染色体q22和14号染色体q24。
Diabetes. 2003 Aug;52(8):2182-6. doi: 10.2337/diabetes.52.8.2182.
6
beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.β细胞基因与糖尿病:转录因子突变的分子与临床特征
Diabetes. 2001 Feb;50 Suppl 1:S94-100. doi: 10.2337/diabetes.50.2007.s94.
7
High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes.斯堪的纳维亚半岛家族性早发糖尿病患者中MODY和线粒体基因突变的高频率。
Diabetologia. 1999 Sep;42(9):1131-7. doi: 10.1007/s001250051281.
8
Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor.肝细胞细胞核因子-1α(一种与糖尿病相关的转录因子)的结构/功能研究
Biochem Biophys Res Commun. 1999 Dec 9;266(1):196-202. doi: 10.1006/bbrc.1999.1747.
9
Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.MODY3基因肝细胞核因子-1α对载脂蛋白M基因表达的调控:单倍剂量不足与血清载脂蛋白M水平降低相关。
Diabetes. 2003 Dec;52(12):2989-95. doi: 10.2337/diabetes.52.12.2989.
10
Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes.最初被归类为患有I型糖尿病的白种人家族中,肝细胞核因子-1α基因的突变。
Diabetologia. 1998 Dec;41(12):1528-31. doi: 10.1007/s001250051101.

引用本文的文献

1
Chinese carrier of the p.Gln444fs variant exhibits enhanced response to sulfonylureas.携带p.Gln444fs变异的中国患者对磺脲类药物表现出增强的反应。
Heliyon. 2024 Jul 23;10(15):e35112. doi: 10.1016/j.heliyon.2024.e35112. eCollection 2024 Aug 15.
2
Prevalence and Clinical Profile of Maturity Onset Diabetes of the Young among People with Diabetes Attending a Tertiary Care Centre.在一家三级护理中心就诊的糖尿病患者中青少年成年起病型糖尿病的患病率及临床特征
Indian J Endocrinol Metab. 2022 Nov-Dec;26(6):543-550. doi: 10.4103/ijem.ijem_334_22. Epub 2023 Feb 7.
3
A novel splice-affecting variant with large population impact on diabetes in Greenland.
一种对格陵兰岛糖尿病有重大人群影响的新型剪接影响变体。
Lancet Reg Health Eur. 2022 Nov 11;24:100529. doi: 10.1016/j.lanepe.2022.100529. eCollection 2023 Jan.
4
Variants influencing age at diagnosis of HNF1A-MODY.影响 HNF1A-MODY 发病年龄的变异。
Mol Med. 2022 Sep 14;28(1):113. doi: 10.1186/s10020-022-00542-0.
5
Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12).精准治疗三个中国年轻起病型糖尿病(MODY12)家系。
Front Endocrinol (Lausanne). 2022 Aug 3;13:858096. doi: 10.3389/fendo.2022.858096. eCollection 2022.
6
Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes.在追求单基因糖尿病精准医学的真正方法中,可操作基因的作用。
Genes (Basel). 2022 Jan 9;13(1):117. doi: 10.3390/genes13010117.
7
A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.一项关于 HNF1A-MODY 最常见因果变异体表型后果的多代研究。
Diabetologia. 2022 Apr;65(4):632-643. doi: 10.1007/s00125-021-05631-z. Epub 2021 Dec 24.
8
Molecular diagnosis of maturity onset diabetes of the young in Iranian patients: improving management.伊朗患者青年发病型成年糖尿病的分子诊断:改善管理
J Diabetes Metab Disord. 2021 Aug 19;20(2):1369-1374. doi: 10.1007/s40200-021-00870-8. eCollection 2021 Dec.
9
Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.年轻的葡萄糖激酶成熟型糖尿病(GCK-MODY)患者的表型异质性
J Clin Res Pediatr Endocrinol. 2017 Sep 1;9(3):246-252. doi: 10.4274/jcrpe.4461. Epub 2017 Jun 30.
10
Identification and functional analysis of c.422_423InsT, a novel mutation of the gene in a patient with diabetes.糖尿病患者中该基因一种新突变c.422_423InsT的鉴定与功能分析
Mol Genet Genomic Med. 2016 Nov 30;5(1):50-65. doi: 10.1002/mgg3.261. eCollection 2017 Jan.